Efficacy of 10% imidacloprid + 2.5% moxidectin topical solution (Advantage Multi(®) for Dogs) for the prevention of heartworm disease and infection all month long

BACKGROUND: Prior work has shown that the levels of moxidectin in dogs treated with Advantage Multi® for Dogs (Bayer Animal Health) remain at a high plasma concentration for the full month after application. The objective of this study was to demonstrate the efficacy of 10% imidacloprid + 2.5% moxid...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowman, Dwight D., Ohmes, Cameon M., Hostetler, Joseph A., Keil, Daniel J., Settje, Terry L., Charles, Samuel D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688421/
https://www.ncbi.nlm.nih.gov/pubmed/29143660
http://dx.doi.org/10.1186/s13071-017-2432-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688421/
https://www.ncbi.nlm.nih.gov/pubmed/29143660
http://dx.doi.org/10.1186/s13071-017-2432-x

Ejemplares similares